Executive management

Fredrik Ullman
CEO since 2021 Born: 1980
Education

BSc in Mechanical Engineering from ETH Zürich and a MEng in Product Development from the KTH Royal Institute of Technology in Stockholm, a MScEng in Industrial engineering and Production, Supply Chain Management and Integrated Product Development and a PhD in Innovation and Technology Management from ETH Zürich.

Other current assignments

Owner of Innoverse GmbH.

Principal work experience

CEO of Indical Bioscience, various positions at Novozymes and Consultant at Bain & Company.

Shareholding in the company

1,907,812 ordinary shares, 1,214,554 C shares.
Subscribed for a total of 250,836 warrants in the Company under LTI 2021.

Henrik Halvorsen
CFO since 2021 Born: 1982
Education

MSc in International Economics and Business from the Stockholm School of Economics.

Other current assignments

Board member of a number of subsidiaries within the Group and Transferator AB (publ) and board member or deputy board member of a number of subsidiaries within the Transferator AB (publ)-group.

Principal work experience

CFO of Nexmune, Group Strategy and M&A Manager at Dometic and Consultant at L.E.K. Consulting.

Shareholding in the company

1,041,910 ordinary shares, 625,146 C shares.
Subscribed for a total of 125,418 warrants in the Company under LTI 2021.

Magnus Kjellberg
CEO of Nextmune since 2017 Born: 1973
Education

MSc in Business and Economics from the Stockholm School of Economics.

Other current assignments

Chairman of the board of a number of subsidiaries within the Group. Board member of a number of subsidiaries within the Group and Nextmune BV, Nextmune US LLC, Nextmune AS, Nextmune Spain S.L., Diavet S.L., I.C.F. S.r.l., DRN S.r.l., and Vetruus Limited.

Principal work experience

VP Corporate Strategy and M&A at Meda.

Shareholding in the company

2,143,061 ordinary shares, 1,367,912 C shares.
Subscribed for a total of 125,418 warrants in the Company under LTI 2021.

Stefano Santarelli
CEO of Indical Bioscience since 2021 Born: 1981
Education

Bachelor of Economics (Honours) at LUISS Guido Carli University in Rome.

Principal work experience

Director at Ontario Teachers’ Pension Plan, Principal at Bain & Company and Consultant at Ernst & Young.

Shareholding in the company

0 ordinary shares, 0 C shares.
0 warrants.

Mikael Sjögren
CEO of VetFamily since 2018 Born: 1977
Education

MSc in Finance and Marketing from the Stockholm School of Economics.

Other current assignments

Chairman of the board and board member of a number of subsidiaries within the Group. Board member of Saluki AB. Deputy board member of Marie-Louise Design AB.

Principal work experience

Group Business Development Director at AniCura, Investment Director at Montagu and Associate at Goldman Sachs.

Shareholding in the company

3,461,635 ordinary shares, 2,209,555 C shares.
0 warrants.

Patrick Gendreau
Co-CEO of Movora since 2020 Born: 1976
Education

BBA in International Business from Université du Québec à Montréal and a MBA in International Business from University of Illinois at Chicago.

Other current assignments

Board member of a number of subsidiaries within the Group.

Principal work experience

CEO of Veterinary Orthopedic Implants.

Shareholding in the company

17,256,029 ordinary shares, 7,876,219 C shares.
Subscribed for a total of 125,418 warrants in the Company under LTI 2021.

Christopher Sidebotham
Co-CEO of Movora since 2020 Born: 1955
Education

BSc in Mechanical Engineering from University of Memphis, US.

Principal work experience

President and CEO of Biomedtrix and Director of Product Development at Stryker and Zimmer.

Shareholding in the company

419,885 ordinary shares, 370,487 C shares.
0 warrants.

Guy C. Spörri
Co-CEO of Movora since 2020 Born: 1980
Education

MSc in Management, Technology and Economics from ETH Zürich.

Other current assignments

Chairman of the board of KYON AG. Board member of Kyon Pharma (US) and Ossium AG.

Principal work experience

CEO of Kyon, General Manager of Joint Replacement Division at Stryker and Sales Manager at Johnson & Johnson.

Shareholding in the company

663,889 ordinary shares, 344,318 C shares.
Subscribed for a total of 83,612 warrants in the Company under LTI 2021.

Martin Bengtson
Head of M&A since 2021 Born: 1981
Education

MSc in Finance from the Stockholm School of Economics.

Other current assignments

Board member of HRR Holding AB and Danzinger Gatt Invest AB.

Principal work experience

Head of M&A at Doktor.se, Group M&A Manager at AniCura and Investment Manager at Nordic Capital.

Shareholding in the company

174,250 ordinary shares, 104,550 C shares.
0 warrants.

Maria Dahllöf Tullberg
Head of Sustainability & IR from Sep 2021 Born: 1981
Education

MSc in Accounting and Financial Management from the Stockholm School of Economics.

Principal work experience

Group Communications Manager at AniCura, Head of Marketing & Communications at Moderna Försäkringar and Consultant at JKL Group.

Independent of

7,300 ordinary shares, 0 C shares.
Subscribed for a total of 83,612 warrants in the Company under LTI 2021.

This website uses cookies for analytics and an improved browsing experience. Read more